3.99Open3.99Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover426.03%IV-91.80%PremiumDec 20, 2024Expiry Date5.67Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7980Delta0.1512Gamma0.32Leverage Ratio-0.0116Theta-0.0029Rho-0.25Eff Leverage0.0013Vega
Pyxis Oncology Stock Discussion
This is the PYXS entire press release from its website
pyxisoncology.c...
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
PDF Version
— PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated HNSCC patients, supporting differentiated mono and front-line combo ther...
No comment yet